[1]
“Formulation And Development Of Topical Bupivacaine Drug Delivery Systems For Pain Management”, Journal of Pharmaceutical Negative Results, pp. 2033–2050, Feb. 2023, doi: 10.47750/pnr.2023.14.S02.244.